410 related articles for article (PubMed ID: 15657354)
1. Epigenetic regulation of O6-methylguanine-DNA methyltransferase gene expression by histone acetylation and methyl-CpG binding proteins.
Danam RP; Howell SR; Brent TP; Harris LC
Mol Cancer Ther; 2005 Jan; 4(1):61-9. PubMed ID: 15657354
[TBL] [Abstract][Full Text] [Related]
2. The essential role of histone H3 Lys9 di-methylation and MeCP2 binding in MGMT silencing with poor DNA methylation of the promoter CpG island.
Zhao W; Soejima H; Higashimoto K; Nakagawachi T; Urano T; Kudo S; Matsukura S; Matsuo S; Joh K; Mukai T
J Biochem; 2005 Mar; 137(3):431-40. PubMed ID: 15809347
[TBL] [Abstract][Full Text] [Related]
3. CpG methylation-dependent repression of the human O6-methylguanine-DNA methyltransferase gene linked to chromatin structure alteration.
Bhakat KK; Mitra S
Carcinogenesis; 2003 Aug; 24(8):1337-45. PubMed ID: 12807730
[TBL] [Abstract][Full Text] [Related]
4. Silencing effect of CpG island hypermethylation and histone modifications on O6-methylguanine-DNA methyltransferase (MGMT) gene expression in human cancer.
Nakagawachi T; Soejima H; Urano T; Zhao W; Higashimoto K; Satoh Y; Matsukura S; Kudo S; Kitajima Y; Harada H; Furukawa K; Matsuzaki H; Emi M; Nakabeppu Y; Miyazaki K; Sekiguchi M; Mukai T
Oncogene; 2003 Dec; 22(55):8835-44. PubMed ID: 14647440
[TBL] [Abstract][Full Text] [Related]
5. Critical role of histone methylation in tumor suppressor gene silencing in colorectal cancer.
Kondo Y; Shen L; Issa JP
Mol Cell Biol; 2003 Jan; 23(1):206-15. PubMed ID: 12482974
[TBL] [Abstract][Full Text] [Related]
6. DNA methylation and histone acetylation regulate the expression of MGMT and chemosensitivity to temozolomide in malignant melanoma cell lines.
Chen YP; Hou XY; Yang CS; Jiang XX; Yang M; Xu XF; Feng SX; Liu YQ; Jiang G
Tumour Biol; 2016 Aug; 37(8):11209-18. PubMed ID: 26943799
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic silencing of O6-methylguanine DNA methyltransferase gene in NiS-transformed cells.
Ji W; Yang L; Yu L; Yuan J; Hu D; Zhang W; Yang J; Pang Y; Li W; Lu J; Fu J; Chen J; Lin Z; Chen W; Zhuang Z
Carcinogenesis; 2008 Jun; 29(6):1267-75. PubMed ID: 18204074
[TBL] [Abstract][Full Text] [Related]
8. Selective association of the methyl-CpG binding protein MBD2 with the silent p14/p16 locus in human neoplasia.
Magdinier F; Wolffe AP
Proc Natl Acad Sci U S A; 2001 Apr; 98(9):4990-5. PubMed ID: 11309512
[TBL] [Abstract][Full Text] [Related]
9. Influence of CpG island methylation status in O6-methylguanine-DNA methyltransferase expression of oral cancer cell lines.
Murakami J; Asaumi J; Maki Y; Tsujigiwa H; Nagatsuka H; Kokeguchi S; Inoue T; Kawasaki S; Tanaka N; MacPhee D; Matsubara N; Kishi K
Oncol Rep; 2004 Aug; 12(2):339-45. PubMed ID: 15254699
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic modulation of tumor suppressor CCAAT/enhancer binding protein alpha activity in lung cancer.
Tada Y; Brena RM; Hackanson B; Morrison C; Otterson GA; Plass C
J Natl Cancer Inst; 2006 Mar; 98(6):396-406. PubMed ID: 16537832
[TBL] [Abstract][Full Text] [Related]
11. Re-expression of methylation-induced tumor suppressor gene silencing is associated with the state of histone modification in gastric cancer cell lines.
Meng CF; Zhu XJ; Peng G; Dai DQ
World J Gastroenterol; 2007 Dec; 13(46):6166-71. PubMed ID: 18069755
[TBL] [Abstract][Full Text] [Related]
12. Heterogeneity in the modification and involvement of chromatin components of the CpG island of the silenced human CDH1 gene in cancer cells.
Koizume S; Tachibana K; Sekiya T; Hirohashi S; Shiraishi M
Nucleic Acids Res; 2002 Nov; 30(21):4770-80. PubMed ID: 12409468
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic silencing of the MGMT gene in cancer.
Soejima H; Zhao W; Mukai T
Biochem Cell Biol; 2005 Aug; 83(4):429-37. PubMed ID: 16094446
[TBL] [Abstract][Full Text] [Related]
14. Promoter histone H3 lysine 9 di-methylation is associated with DNA methylation and aberrant expression of p16 in gastric cancer cells.
Meng CF; Zhu XJ; Peng G; Dai DQ
Oncol Rep; 2009 Nov; 22(5):1221-7. PubMed ID: 19787243
[TBL] [Abstract][Full Text] [Related]
15. Coordinated changes in DNA methylation and histone modifications regulate silencing/derepression of luteinizing hormone receptor gene transcription.
Zhang Y; Fatima N; Dufau ML
Mol Cell Biol; 2005 Sep; 25(18):7929-39. PubMed ID: 16135786
[TBL] [Abstract][Full Text] [Related]
16. Demethylation by 5-aza-2'-deoxycytidine in colorectal cancer cells targets genomic DNA whilst promoter CpG island methylation persists.
Mossman D; Kim KT; Scott RJ
BMC Cancer; 2010 Jul; 10():366. PubMed ID: 20618997
[TBL] [Abstract][Full Text] [Related]
17. Chromatin composition alterations and the critical role of MeCP2 for epigenetic silencing of progesterone receptor-B gene in endometrial cancers.
Chu Y; Wang Y; Zhang G; Chen H; Dowdy SC; Xiong Y; Liu F; Zhang R; Li J; Jiang SW
Cell Mol Life Sci; 2014 Sep; 71(17):3393-408. PubMed ID: 24531693
[TBL] [Abstract][Full Text] [Related]
18. Role of histone modifications and DNA methylation in the regulation of O6-methylguanine-DNA methyltransferase gene expression in human stomach cancer cells.
Meng CF; Zhu XJ; Peng G; Dai DQ
Cancer Invest; 2010 May; 28(4):331-9. PubMed ID: 19857042
[TBL] [Abstract][Full Text] [Related]
19. Precipitous release of methyl-CpG binding protein 2 and histone deacetylase 1 from the methylated human multidrug resistance gene (MDR1) on activation.
El-Osta A; Kantharidis P; Zalcberg JR; Wolffe AP
Mol Cell Biol; 2002 Mar; 22(6):1844-57. PubMed ID: 11865062
[TBL] [Abstract][Full Text] [Related]
20. Inhibitors of histone deacetylase and DNA methyltransferase synergistically activate the methylated metallothionein I promoter by activating the transcription factor MTF-1 and forming an open chromatin structure.
Ghoshal K; Datta J; Majumder S; Bai S; Dong X; Parthun M; Jacob ST
Mol Cell Biol; 2002 Dec; 22(23):8302-19. PubMed ID: 12417732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
